Michaël Domanski

22.7k total citations · 3 hit papers
122 papers, 12.8k citations indexed

About

Michaël Domanski is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Michaël Domanski has authored 122 papers receiving a total of 12.8k indexed citations (citations by other indexed papers that have themselves been cited), including 96 papers in Cardiology and Cardiovascular Medicine, 40 papers in Surgery and 19 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Michaël Domanski's work include Heart Failure Treatment and Management (29 papers), Cardiac electrophysiology and arrhythmias (28 papers) and Cardiovascular Function and Risk Factors (25 papers). Michaël Domanski is often cited by papers focused on Heart Failure Treatment and Management (29 papers), Cardiac electrophysiology and arrhythmias (28 papers) and Cardiovascular Function and Risk Factors (25 papers). Michaël Domanski collaborates with scholars based in United States, Canada and Spain. Michaël Domanski's co-authors include Marc A. Pfeffer, George Johnson, Gust H. Bardy, Kerry L. Lee, Jill Anderson, Daniel B. Mark, Jeanne E. Poole, Robin Boineau, James E. Ip and Linda Davidson‐Ray and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and JAMA.

In The Last Decade

Michaël Domanski

120 papers receiving 12.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart Failure

2005 4.4k citations Michaël Domanski et al. New England Journal of Medicine profile →
A Sensitive Cardiac Troponin T Assay in Stable Coronary Artery Disease

2009 667 citations Marc S. Sabatine, Michaël Domanski et al. New England Journal of Medicine profile →
Time Course of LDL Cholesterol Exposure and Cardiovascular Disease Event Risk

2020 211 citations Michaël Domanski, Xin Tian et al. Journal of the American College of Cardiology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michaël Domanski United States	47	10.3k	2.6k	1.3k	1.1k	963	122	12.8k
Alain Cohen‐Solal France	61	11.0k 1.1×	1.7k 0.7×	932 0.7×	1.9k 1.8×	896 0.9×	250	13.7k
Charles R. Bridges United States	38	6.1k 0.6×	3.5k 1.3×	1.4k 1.0×	849 0.8×	537 0.6×	114	9.8k
José Antônio Franchini Ramires Brazil	45	5.4k 0.5×	3.4k 1.3×	1.8k 1.3×	965 0.9×	1.0k 1.0×	486	9.5k
Norman Sharpe New Zealand	38	7.4k 0.7×	2.0k 0.8×	1.2k 0.9×	770 0.7×	858 0.9×	113	9.8k
Jalal K. Ghali United States	50	7.7k 0.7×	1.2k 0.4×	1.1k 0.8×	1.5k 1.4×	974 1.0×	161	9.9k
Petar Seferović Serbia	44	9.8k 0.9×	2.5k 0.9×	802 0.6×	1.4k 1.3×	1.3k 1.3×	180	12.2k
Tamara B. Horwich United States	42	6.3k 0.6×	2.0k 0.7×	617 0.5×	959 0.9×	1.2k 1.2×	125	10.7k
Hans‐Peter Brunner‐La Rocca Netherlands	57	8.0k 0.8×	3.2k 1.2×	1.0k 0.8×	2.2k 2.1×	648 0.7×	327	11.7k
Susan J. Zieman United States	35	6.5k 0.6×	2.1k 0.8×	1.7k 1.3×	660 0.6×	814 0.8×	62	9.1k
Robert S. McKelvie Canada	62	11.4k 1.1×	1.1k 0.4×	779 0.6×	1.3k 1.3×	1.4k 1.4×	253	14.5k

Countries citing papers authored by Michaël Domanski

Since Specialization

Citations

This map shows the geographic impact of Michaël Domanski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michaël Domanski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michaël Domanski more than expected).

Fields of papers citing papers by Michaël Domanski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michaël Domanski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michaël Domanski. The network helps show where Michaël Domanski may publish in the future.

Co-authorship network of co-authors of Michaël Domanski

This figure shows the co-authorship network connecting the top 25 collaborators of Michaël Domanski. A scholar is included among the top collaborators of Michaël Domanski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michaël Domanski. Michaël Domanski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Reges, Orna, Hongyan Ning, John T. Wilkins, et al.. (2020). Association of Cumulative Systolic Blood Pressure With Long-Term Risk of Cardiovascular Disease and Healthy Longevity. Hypertension. 77(2). 347–356. 54 indexed citations

Domanski, Michaël, Kenneth W. Mahaffey, Sorin J. Brener, et al.. (2012). Association of Myocardial Enzyme Elevation and Survival Following Coronary Artery Bypass Graft Surgery. Survey of Anesthesiology. 56(1). 5–6. 44 indexed citations

Fleg, Jerome L., Gregg W. Stone, Zahi A. Fayad, et al.. (2012). Detection of High-Risk Atherosclerotic Plaque. JACC. Cardiovascular imaging. 5(9). 941–955. 165 indexed citations

Domanski, Michaël & Sonja M. McKinlay. (2009). Successful randomized trials : a handbook for the 21st century. 10 indexed citations

Domanski, Michaël, Xin Tian, Jerome L. Fleg, et al.. (2008). Pleiotropic Effect of Lovastatin, With and Without Cholestyramine, in the Post Coronary Artery Bypass Graft (Post CABG) Trial. The American Journal of Cardiology. 102(8). 1023–1027. 14 indexed citations

Farkouh, Michael E., George Dangas, Martin B. Leon, et al.. (2008). Design of the Future REvascularization Evaluation in patients with Diabetes mellitus: Optimal management of Multivessel disease (FREEDOM) Trial. American Heart Journal. 155(2). 215–223. 113 indexed citations

Chew, Emily Y., Walter T. Ambrosius, Craig M. Greven, et al.. (2007). Rationale, Design, and Methods of the Action to Control Cardiovascular Risk in Diabetes Eye Study (ACCORD-EYE). The American Journal of Cardiology. 99(12). S103–S111. 48 indexed citations

Domanski, Michaël, Xin Tian, Mark C. Haigney, & Bertram Pitt. (2006). Diuretic Use, Progressive Heart Failure, and Death in Patients in the DIG Study. Journal of Cardiac Failure. 12(5). 327–332. 76 indexed citations

Cooper, Howard A., Michaël Domanski, Yves Rosenberg, et al.. (2004). Acute ST-segment elevation myocardial infarction and prior stroke: An analysis from the Magnesium in Coronaries (MAGIC) trial. American Heart Journal. 148(6). 1012–1019. 14 indexed citations

10.

Domanski, Michaël, Heidi Krause‐Steinrauf, Barry M. Massie, et al.. (2003). A comparative analysis of the results from 4 trials of β-blocker therapy for heart failure: BEST, CIBIS-II, MERIT-HF, and COPERNICUS. Journal of Cardiac Failure. 9(5). 354–363. 123 indexed citations

11.

Domanski, Michaël, James E. Norman, Bertram Pitt, et al.. (2003). Diuretic use, progressive heart failure, and death in patients in the studies of left ventricular dysfunction (SOLVD). Journal of the American College of Cardiology. 42(4). 705–708. 250 indexed citations

12.

Schron, Eleanor & Michaël Domanski. (2003). Implantable Devices Benefit Patients With Cardiovascular Diseases. The Journal of Cardiovascular Nursing. 18(5). 337–342. 1 indexed citations

13.

Steinberg, Jonathan S., James B. Martins, Saihari Sadanandan, et al.. (2001). Antiarrhythmic drug use in the implantable defibrillator arm of the Antiarrhythmics Versus Implantable Defibrillators (AVID) Study. American Heart Journal. 142(3). 520–529. 40 indexed citations

14.

Domanski, Michaël, Douglas P. Zipes, David G. Benditt, et al.. (2001). Central Clinical Research Issues in Electrophysiology: Report of the NASPE Committee. Pacing and Clinical Electrophysiology. 24(4). 526–534. 4 indexed citations

15.

Exner, Derek V., Daniel L. Dries, Michaël Domanski, & Jay N. Cohn. (2001). Lesser Response to Angiotensin-Converting–Enzyme Inhibitor Therapy in Black as Compared with White Patients with Left Ventricular Dysfunction. New England Journal of Medicine. 344(18). 1351–1357. 397 indexed citations

16.

Domanski, Michaël, Kim Sutton-Tyrrell, Gary F. Mitchell, et al.. (2001). Determinants and prognostic information provided by pulse pressure in patients with coronary artery disease undergoing revascularization (the Balloon Angioplasty Revascularization Investigation [BARI]). The American Journal of Cardiology. 87(6). 675–679. 31 indexed citations

17.

Cooper, Howard A., Derek V. Exner, & Michaël Domanski. (2000). Light-to-moderate alcohol consumption and prognosis in patients with left ventricular systolic dysfunction. Journal of the American College of Cardiology. 35(7). 1753–1759. 78 indexed citations

18.

Domanski, Michaël. (2000). Beta-blocker Evaluation of Survival Trial. 202–203. 25 indexed citations

19.

Domanski, Michaël, Andrew E. Epstein, Alfred P. Hallstrom, et al.. (1999). Relative effectiveness of the implantable cardioverter-defibrillator and antiarrhythmic drugs in patients with varying degrees of left ventricular dysfunction who have survived malignant ventricular arrhythmias. Journal of the American College of Cardiology. 34(4). 1090–1095. 130 indexed citations

20.

Shawl, Fayaz A., et al.. (1990). Percutaneous cardiopulmonary bypass support in the catheterization laboratory: Technique and complications. American Heart Journal. 120(1). 195–203. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact